Ocrevus 300 MG/1 ML 1S
Ended Awarded
- Contract number
- SPE2DX25FJGRF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,039
Award facts
- Contract value 100% obligated
- $24,038.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense's Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of OCREVUS 300 mg/1 ml in a single-use formulation. This is a firm fixed-price delivery order valued at $24,038.58, with an ultimate completion date of June 20, 2025. No set-aside designation was used in this competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. OCREVUS (ocrelizumab) is a monoclonal antibody used to treat multiple sclerosis and related neurological conditions, representing a specialty pharmaceutical product within the company's broader federal contract portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The company's federal contract awards demonstrate significant capability in fulfilling specialized medical procurement requirements, including specialty medications, vaccines, and medical devices across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DX25FJGRF?
SPE2DX25FJGRF was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on June 18, 2025.
How much is contract SPE2DX25FJGRF worth?
The government has obligated $24,039 on SPE2DX25FJGRF.
Is contract SPE2DX25FJGRF an order under another contract?
Yes. SPE2DX25FJGRF is a delivery order under SPE2DX15D7062, an indefinite delivery contract.
Was contract SPE2DX25FJGRF competed?
The extent of competition for SPE2DX25FJGRF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award